2025-05-09 19:58:14, GGRNA : RefSeq release 60 (20130726)
LOCUS NM_001206954 1321 bp mRNA linear PRI 07-JUL-2013 DEFINITION Homo sapiens advanced glycosylation end product-specific receptor (AGER), transcript variant 8, mRNA. ACCESSION NM_001206954 VERSION NM_001206954.1 GI:332800984 KEYWORDS RefSeq. SOURCE Homo sapiens (human) ORGANISM Homo sapiens Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo. REFERENCE 1 (bases 1 to 1321) AUTHORS Tang,S.C., Wang,Y.C., Li,Y.I., Lin,H.C., Manzanero,S., Hsieh,Y.H., Phipps,S., Hu,C.J., Chiou,H.Y., Huang,Y.S., Yang,W.S., Mattson,M.P., Arumugam,T.V. and Jeng,J.S. TITLE Functional role of soluble receptor for advanced glycation end products in stroke JOURNAL Arterioscler. Thromb. Vasc. Biol. 33 (3), 585-594 (2013) PUBMED 23288172 REMARK GeneRIF: Early poststroke plasma sRAGE may play a protective role in ischemic stroke by capturing HMGB1. REFERENCE 2 (bases 1 to 1321) AUTHORS Djerbi,N., Dziunycz,P.J., Reinhardt,D., Iotzova-Weiss,G., Hafner,J., Lauchli,S., French,L.E. and Hofbauer,G.F. TITLE Influence of cyclosporin and prednisolone on RAGE, S100A8/A9, and NFkappaB expression in human keratinocytes JOURNAL JAMA Dermatol 149 (2), 236-237 (2013) PUBMED 23426492 REMARK GeneRIF: The influence of immunosuppressive drugs on S100A8/A9-RAGE mRNA expression may suggest a role of these proteins in early-stage SCC development in immunosuppressed patients REFERENCE 3 (bases 1 to 1321) AUTHORS Wei,W., Lampe,L., Park,S., Vangara,B.S., Waldo,G.S., Cabantous,S., Subaran,S.S., Yang,D., Lakatta,E.G. and Lin,L. TITLE Disulfide bonds within the C2 domain of RAGE play key roles in its dimerization and biogenesis JOURNAL PLoS ONE 7 (12), E50736 (2012) PUBMED 23284645 REMARK GeneRIF: RAGE intermolecular disulfide bond REFERENCE 4 (bases 1 to 1321) AUTHORS Hancock,D.B., Artigas,M.S., Gharib,S.A., Henry,A., Manichaikul,A., Ramasamy,A., Loth,D.W., Imboden,M., Koch,B., McArdle,W.L., Smith,A.V., Smolonska,J., Sood,A., Tang,W., Wilk,J.B., Zhai,G., Zhao,J.H., Aschard,H., Burkart,K.M., Curjuric,I., Eijgelsheim,M., Elliott,P., Gu,X., Harris,T.B., Janson,C., Homuth,G., Hysi,P.G., Liu,J.Z., Loehr,L.R., Lohman,K., Loos,R.J., Manning,A.K., Marciante,K.D., Obeidat,M., Postma,D.S., Aldrich,M.C., Brusselle,G.G., Chen,T.H., Eiriksdottir,G., Franceschini,N., Heinrich,J., Rotter,J.I., Wijmenga,C., Williams,O.D., Bentley,A.R., Hofman,A., Laurie,C.C., Lumley,T., Morrison,A.C., Joubert,B.R., Rivadeneira,F., Couper,D.J., Kritchevsky,S.B., Liu,Y., Wjst,M., Wain,L.V., Vonk,J.M., Uitterlinden,A.G., Rochat,T., Rich,S.S., Psaty,B.M., O'Connor,G.T., North,K.E., Mirel,D.B., Meibohm,B., Launer,L.J., Khaw,K.T., Hartikainen,A.L., Hammond,C.J., Glaser,S., Marchini,J., Kraft,P., Wareham,N.J., Volzke,H., Stricker,B.H., Spector,T.D., Probst-Hensch,N.M., Jarvis,D., Jarvelin,M.R., Heckbert,S.R., Gudnason,V., Boezen,H.M., Barr,R.G., Cassano,P.A., Strachan,D.P., Fornage,M., Hall,I.P., Dupuis,J., Tobin,M.D. and London,S.J. TITLE Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function JOURNAL PLoS Genet. 8 (12), E1003098 (2012) PUBMED 23284291 REFERENCE 5 (bases 1 to 1321) AUTHORS Hudson,B.I., Carter,A.M., Harja,E., Kalea,A.Z., Arriero,M., Yang,H., Grant,P.J. and Schmidt,A.M. TITLE Identification, classification, and expression of RAGE gene splice variants JOURNAL FASEB J. 22 (5), 1572-1580 (2008) PUBMED 18089847 REMARK GeneRIF: RAGE_v1 variant is the primary secreted soluble isoform of RAGE. identification of functional splice variants of RAGE underscores biological diversity of the RAGE gene & will aid in understanding of the gene in the normal & pathological state. REFERENCE 6 (bases 1 to 1321) AUTHORS Nozaki,I., Watanabe,T., Kawaguchi,M., Akatsu,H., Tsuneyama,K., Yamamoto,Y., Ohe,K., Yonekura,H., Yamada,M. and Yamamoto,H. TITLE Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains JOURNAL Arch. Histol. Cytol. 70 (5), 279-290 (2007) PUBMED 18431028 REMARK GeneRIF: low expression of endogenous secretory RAGE in the hippocampus would be associated with the development of Alzheimer's disease REFERENCE 7 (bases 1 to 1321) AUTHORS Ritthaler,U., Deng,Y., Zhang,Y., Greten,J., Abel,M., Sido,B., Allenberg,J., Otto,G., Roth,H., Bierhaus,A. et al. TITLE Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease JOURNAL Am. J. Pathol. 146 (3), 688-694 (1995) PUBMED 7887450 REFERENCE 8 (bases 1 to 1321) AUTHORS Vissing,H., Aagaard,L., Tommerup,N. and Boel,E. TITLE Localization of the human gene for advanced glycosylation end product-specific receptor (AGER) to chromosome 6p21.3 JOURNAL Genomics 24 (3), 606-608 (1994) PUBMED 7713518 REFERENCE 9 (bases 1 to 1321) AUTHORS Sugaya,K., Fukagawa,T., Matsumoto,K., Mita,K., Takahashi,E., Ando,A., Inoko,H. and Ikemura,T. TITLE Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3 JOURNAL Genomics 23 (2), 408-419 (1994) PUBMED 7835890 REFERENCE 10 (bases 1 to 1321) AUTHORS Neeper,M., Schmidt,A.M., Brett,J., Yan,S.D., Wang,F., Pan,Y.C., Elliston,K., Stern,D. and Shaw,A. TITLE Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins JOURNAL J. Biol. Chem. 267 (21), 14998-15004 (1992) PUBMED 1378843 COMMENT REVIEWED REFSEQ: This record has been curated by NCBI staff. The reference sequence was derived from AK298100.1, EU117141.1 and BM971899.1. Summary: The advanced glycosylation end product (AGE) receptor encoded by this gene is a member of the immunoglobulin superfamily of cell surface receptors. It is a multiligand receptor, and besides AGE, interacts with other molecules implicated in homeostasis, development, and inflammation, and certain diseases, such as diabetes and Alzheimer's disease. Many alternatively spliced transcript variants encoding different isoforms, as well as non-protein-coding variants, have been described for this gene (PMID:18089847). [provided by RefSeq, May 2011]. Transcript Variant: This variant (8, also known as RAGE_v8) lacks two internal coding exons, and uses an alternate donor splice site at another coding exon compared to variant 1. This results in a frame-shift, and a shorter isoform (8) with a distinct C-terminus compared to isoform 1. Sequence Note: This Refseq, containing two in-frame translation initiation codons (at nt 8-10 and nt 101-103), is annotated with a CDS starting from the downstream AUG (dAUG) because the AGE receptor encoded by this gene is a known type 1 transmembrane protein requiring signal peptide for its function, and a signal peptide of 22 aa is predicted for the dAUG initiated protein. Translation initiation from the upstream AUG (uAUG) will add an extra 31 aa to the N-terminus, and no signal peptide is predicted for the uAUG initiated protein. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript exon combination :: EU117141.1 [ECO:0000332] RNAseq introns :: single sample supports all introns ERS025088 [ECO:0000348] ##Evidence-Data-END## ##RefSeq-Attributes-START## CDS uses downstream in-frame AUG :: downstream AUG is associated with N-terminal localization signal ##RefSeq-Attributes-END## COMPLETENESS: complete on the 3' end. PRIMARY REFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-922 AK298100.1 3-924 923-1149 EU117141.1 833-1059 1150-1301 AK298100.1 1339-1490 1302-1321 BM971899.1 1-20 c FEATURES Location/Qualifiers source 1..1321 /organism="Homo sapiens" /mol_type="mRNA" /db_xref="taxon:9606" /chromosome="6" /map="6p21.3" gene 1..1321 /gene="AGER" /gene_synonym="RAGE" /note="advanced glycosylation end product-specific receptor" /db_xref="GeneID:177" /db_xref="HGNC:320" /db_xref="MIM:600214" exon 1..152 /gene="AGER" /gene_synonym="RAGE" /inference="alignment:Splign:1.39.8" misc_feature 2..4 /gene="AGER" /gene_synonym="RAGE" /note="upstream in-frame stop codon" misc_feature 8..10 /gene="AGER" /gene_synonym="RAGE" /note="alternative translation initiation codon" CDS 101..1078 /gene="AGER" /gene_synonym="RAGE" /note="isoform 8 precursor is encoded by transcript variant 8; RAGE isoform sRAGE-delta; RAGE isoform NtRAGE-delta" /codon_start=1 /product="advanced glycosylation end product-specific receptor isoform 8 precursor" /protein_id="NP_001193883.1" /db_xref="GI:332800985" /db_xref="GeneID:177" /db_xref="HGNC:320" /db_xref="MIM:600214" /translation="
MAAGTAVGAWVLVLSLWGAVVGAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWEPVPLEEVQLVVEPEGGAVAPGGTVTLTCEVPAQPSPQIHWMKDNQARRGQLQVRGLIKSGKQKIAPNTCDWGDGQQERNGRPQKTRRKRRSVQN
" sig_peptide 101..166 /gene="AGER" /gene_synonym="RAGE" mat_peptide 167..1075 /gene="AGER" /gene_synonym="RAGE" /product="advanced glycosylation end product-specific receptor isoform 8" misc_feature 200..433 /gene="AGER" /gene_synonym="RAGE" /note="Immunoglobulin domain; Region: Ig; cd00096" /db_xref="CDD:143165" misc_feature 470..757 /gene="AGER" /gene_synonym="RAGE" /note="CD80-like C2-set immunoglobulin domain; Region: C2-set_2; pfam08205" /db_xref="CDD:203874" misc_feature 851..>928 /gene="AGER" /gene_synonym="RAGE" /note="Immunoglobulin C-2 Type; Region: IGc2; smart00408" /db_xref="CDD:197706" variation 106 /gene="AGER" /gene_synonym="RAGE" /replace="a" /replace="t" /db_xref="dbSNP:1800684" exon 153..259 /gene="AGER" /gene_synonym="RAGE" /inference="alignment:Splign:1.39.8" variation 183 /gene="AGER" /gene_synonym="RAGE" /replace="c" /replace="t" /db_xref="dbSNP:17846804" exon 260..455 /gene="AGER" /gene_synonym="RAGE" /inference="alignment:Splign:1.39.8" STS 282..483 /gene="AGER" /gene_synonym="RAGE" /standard_name="MARC_10431-10432:999637141:1" /db_xref="UniSTS:267139" variation 344 /gene="AGER" /gene_synonym="RAGE" /replace="a" /replace="g" /db_xref="dbSNP:2070600" STS 364..825 /gene="AGER" /gene_synonym="RAGE" /standard_name="PMC162222P2" /db_xref="UniSTS:271464" variation 441 /gene="AGER" /gene_synonym="RAGE" /replace="a" /replace="g" /db_xref="dbSNP:17846806" exon 456..520 /gene="AGER" /gene_synonym="RAGE" /inference="alignment:Splign:1.39.8" exon 521..608 /gene="AGER" /gene_synonym="RAGE" /inference="alignment:Splign:1.39.8" STS 584..823 /gene="AGER" /gene_synonym="RAGE" /standard_name="PMC203021P1" /db_xref="UniSTS:271895" exon 609..791 /gene="AGER" /gene_synonym="RAGE" /inference="alignment:Splign:1.39.8" exon 792..922 /gene="AGER" /gene_synonym="RAGE" /inference="alignment:Splign:1.39.8" variation 821 /gene="AGER" /gene_synonym="RAGE" /replace="c" /replace="g" /db_xref="dbSNP:17846799" exon 923..1031 /gene="AGER" /gene_synonym="RAGE" /inference="alignment:Splign:1.39.8" exon 1032..1303 /gene="AGER" /gene_synonym="RAGE" /inference="alignment:Splign:1.39.8" STS 1129..1303 /gene="AGER" /gene_synonym="RAGE" /standard_name="D6S1871" /db_xref="UniSTS:54378" polyA_signal 1281..1286 /gene="AGER" /gene_synonym="RAGE" polyA_site 1303 /gene="AGER" /gene_synonym="RAGE" ORIGIN
ctgaaagatgggggctggagagagggtgcaggccccacctagggcggaggccacagcagggagaggggcagacagagccaggaccctggaaggaagcaggatggcagccggaacagcagttggagcctgggtgctggtcctcagtctgtggggggcagtagtaggtgctcaaaacatcacagcccggattggcgagccactggtgctgaagtgtaagggggcccccaagaaaccaccccagcggctggaatggaaactgaacacaggccggacagaagcttggaaggtcctgtctccccagggaggaggcccctgggacagtgtggctcgtgtccttcccaacggctccctcttccttccggctgtcgggatccaggatgaggggattttccggtgccaggcaatgaacaggaatggaaaggagaccaagtccaactaccgagtccgtgtctaccagattcctgggaagccagaaattgtagattctgcctctgaactcacggctggtgttcccaataaggtggggacatgtgtgtcagagggaagctaccctgcagggactcttagctggcacttggatgggaagcccctggtgcctaatgagaagggagtatctgtgaaggaacagaccaggagacaccctgagacagggctcttcacactgcagtcggagctaatggtgaccccagcccggggaggagatccccgtcccaccttctcctgtagcttcagcccaggccttccccgacaccgggccttgcgcacagcccccatccagccccgtgtctgggagcctgtgcctctggaggaggtccaattggtggtggagccagaaggtggagcagtagctcctggtggaaccgtaaccctgacctgtgaagtccctgcccagccctctcctcaaatccactggatgaaggataaccaggcgaggaggggccaactgcaggtgaggggtttgataaagtcagggaagcagaagatagcccccaacacatgtgactggggggatggtcaacaagaaaggaatggaaggccccagaaaaccaggaggaagaggaggagcgtgcagaactgaatcagtcggaggaacctgaggcaggcgagagtagtactggagggccttgaggggcccacagacagatcccatccatcagctcccttttctttttcccttgaactgttctggcctcagaccaactctctcctgtataatctctctcctgtataaccccaccttgccaagctttcttctacaaccagagccccccacaatgatgattaaacacctgacacatcttgcaaaaaaaaaaaaaaaaaa
//
ANNOTATIONS from NCBI Entrez Gene (20130726): GeneID:177 -> Molecular function: GO:0004872 [receptor activity] evidence: TAS GeneID:177 -> Molecular function: GO:0004888 [transmembrane signaling receptor activity] evidence: TAS GeneID:177 -> Molecular function: GO:0005515 [protein binding] evidence: IPI GeneID:177 -> Molecular function: GO:0044548 [S100 protein binding] evidence: IPI GeneID:177 -> Biological process: GO:0006954 [inflammatory response] evidence: IEA GeneID:177 -> Biological process: GO:0007166 [cell surface receptor signaling pathway] evidence: TAS GeneID:177 -> Biological process: GO:0009611 [response to wounding] evidence: TAS GeneID:177 -> Biological process: GO:0031175 [neuron projection development] evidence: IGI GeneID:177 -> Biological process: GO:0045087 [innate immune response] evidence: TAS GeneID:177 -> Biological process: GO:0050930 [induction of positive chemotaxis] evidence: IEA GeneID:177 -> Biological process: GO:0051092 [positive regulation of NF-kappaB transcription factor activity] evidence: IDA GeneID:177 -> Cellular component: GO:0005576 [extracellular region] evidence: IEA GeneID:177 -> Cellular component: GO:0005886 [plasma membrane] evidence: TAS GeneID:177 -> Cellular component: GO:0005887 [integral to plasma membrane] evidence: TAS
by
@meso_cacase at
DBCLS
This page is licensed under a Creative Commons Attribution 2.1 Japan License.